| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/07/2005 | WO2005060642A2 Rationally designed antibodies |
| 07/07/2005 | WO2005060625A2 Grp receptor-related methods for treating and preventing fear-related disorders |
| 07/07/2005 | WO2005060541A2 Peptides and methods for inducing cellular resistance to infection |
| 07/07/2005 | WO2005060479A2 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 07/07/2005 | WO2005060375A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/07/2005 | WO2005060364A2 Spatial for altering cell proliferation |
| 07/07/2005 | WO2005060350A2 Diastereomeric peptides useful as inhibitors of membrane protein assembly |
| 07/07/2005 | WO2005060328A2 ENCODING NUCLEOTIDES OF GENES FROM THE CHROMOSOME OF THE BACTERIUM Mycoplasma hyopneumoniae, EXPRESSION AND ACTIVITY OF THE POLYNUCLEOTIDES AND THEIR APPLICATIONS |
| 07/07/2005 | WO2005050198A3 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 07/07/2005 | WO2005044844A3 Protozoan strains of reduced virulence and use thereof |
| 07/07/2005 | WO2005042693A3 Hla-e chimeric molecule |
| 07/07/2005 | WO2005040193A3 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 07/07/2005 | WO2005040192A3 Human cathelicidin antimicrobial peptides |
| 07/07/2005 | WO2005038006A3 Chimeric metabotropic glutamate receptors and uses thereof |
| 07/07/2005 | WO2005038003A3 Compositions and methods for generation of positive and negative selection vectors |
| 07/07/2005 | WO2005035556A3 Sars-coronavirus virus-like particles and methods of use |
| 07/07/2005 | WO2005033284A3 Compositions and methods for gene expression |
| 07/07/2005 | WO2005030806A3 Norovirus monoclonal antibodies and peptides |
| 07/07/2005 | WO2005026205A3 Genetic products which are differentially expressed in tumours and use thereof |
| 07/07/2005 | WO2005023979A3 Isolated s. mansoni nucleic acid molecules and uses thereof |
| 07/07/2005 | WO2005021025A3 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 07/07/2005 | WO2005020785A3 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| 07/07/2005 | WO2005016966A3 Intron fusion proteins, and methods of identifying and using same |
| 07/07/2005 | WO2005016266A3 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 07/07/2005 | WO2005014798A3 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells |
| 07/07/2005 | WO2005014639A3 Periodic antimicrobial peptides |
| 07/07/2005 | WO2005014617A3 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 07/07/2005 | WO2005000894A3 Binding molecules for the treatment of myeloid cell malignancies |
| 07/07/2005 | WO2004108922A3 Use of aav comprising a capsid protein from aav7 or aav8 for the delivery of genes encoding apoprotein a or e genes to the liver |
| 07/07/2005 | WO2004108757A3 Antimicrobial polypeptides |
| 07/07/2005 | WO2004103149A3 Genes encoding single chain human leukocyte antigen e (hla-e) proteins to prevent natural killer cell-mediated cytotoxicity |
| 07/07/2005 | WO2004085666A3 Secreted proteins |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | WO2004072296A3 Compositions for modulating immune cell activity and methods for detection thereof |
| 07/07/2005 | WO2004052290A3 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 07/07/2005 | WO2004050849A8 Recombinant immunotoxin and use in treating tumors |
| 07/07/2005 | WO2004031768A3 Method for screening modulators of mitochondrial functioning |
| 07/07/2005 | WO2004026265A9 Compositions and methods for treatment of herpesvirus infections |
| 07/07/2005 | WO2004024892A8 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | WO2003052073A3 Novel corn event |
| 07/07/2005 | WO2002078732A9 A noval vaccine formulation consisting of dna vaccine inactivated virus |
| 07/07/2005 | US20050150016 Method for producing a recombinant protein using pollen |
| 07/07/2005 | US20050150015 Plants with improved morphogenesis and method of constructing the same |
| 07/07/2005 | US20050150011 Viral amplification of recombinant messenger RNA in transgenic plants |
| 07/07/2005 | US20050150008 Compositions isolated from forage grasses and methods of use |
| 07/07/2005 | US20050150004 Insecticidal proteins for use in reducing sensitivity of plants to pests; biological pest control |
| 07/07/2005 | US20050150000 Immunoglobulin for use as tool in detection of thermal hysteresis protein; freeze protection; de-icying solutions |
| 07/07/2005 | US20050149998 Transgenic mouse embryonic stem cells for use as models in expression of heterologous genes |
| 07/07/2005 | US20050149995 Using transgenic animal cells as bioreactor for propagation of connective tissue protein for use in treatment of collagen diseases |
| 07/07/2005 | US20050149994 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/07/2005 | US20050149993 Transgenic mouse for use as model in identifying modulators for prevention and treatment of circadian rythm disorders |
| 07/07/2005 | US20050148765 Expression vector comprising nucleotide sequences coding cell cycle regulatory protein for use as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148763 Peg-binding pth or peg-binding pth derivative |
| 07/07/2005 | US20050148762 Using citric acid precipitation to isolate g protein coupled receptor protein |
| 07/07/2005 | US20050148761 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148525 Nucleic acid markers |
| 07/07/2005 | US20050148516 Sugar transferase gnt-v having angiogenic effect |
| 07/07/2005 | US20050148515 Peptidomimetics; determining ability to bind growth hormone secretagogue; ghrelin agonists; appetite stimulation; dietetics |
| 07/07/2005 | US20050148513 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/07/2005 | US20050148511 Fibroblast growth factor (FGF); enhanced receptor subtype specificity and/or affinity; for treatment of skeletal dysplasia, osteoporosis and enhancing bone fracture healing and cartilage healing processes; mitogens |
| 07/07/2005 | US20050148510 Protein with a hedgehog N-terminal domain covalently bound to a polypeptide with 10-30 hydrophobic amino acids, C 8-24 aliphatic, saturated or unsaturated hydrocarbon residues, or a hydrophobic thio group |
| 07/07/2005 | US20050148509 Insulin-like growth factor; fusion proteins; chimera; apoptosis |
| 07/07/2005 | US20050148508 For diagnosis and treatment of angiogenesis-related diseases; nerve growth factors |
| 07/07/2005 | US20050148507 Monocyte chemoattractant proteins incubated in phosphate buffer; for treatment of coronary artery disease, peripheral arterial occlusive disease, cerebral and mesenterial arterial occlusive diseases |
| 07/07/2005 | US20050148506 Novel method of modulating bone-related activity |
| 07/07/2005 | US20050148505 Genes and agents to regulate follicular development, ovulation cycle and steriodogenesis |
| 07/07/2005 | US20050148498 Metalloprotease inhibiting activity, in particular collagenase and gelatinase, treating humans or mammals suffering from a condition or disease related to excessive degeneration of support by a metalloprotease; treat inflammatory diseases: arthrosis, parodontosis or ulcers |
| 07/07/2005 | US20050148497 Method for administering glp-1 molecules |
| 07/07/2005 | US20050148087 Isobarically labeled analytes and fragment ions derived therefrom |
| 07/07/2005 | US20050148076 Packaging cell lines for generation of high titers of recombinant AAV vectors |
| 07/07/2005 | US20050148075 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148061 Hybrid plasmid pzzsa coding the synthesis of angiogenis of angiogenin protein and escherichia coli bl21(des) pzzsa strain as the the superoducer of the recombinant chimeric protein of human angiogenin |
| 07/07/2005 | US20050148058 Protein stabilization |
| 07/07/2005 | US20050148038 Biomimetic chemotaxis receptor-signal complex for use in identifying modulators of B-cell and T-cell receptor signaling pathways; immunotherapy |
| 07/07/2005 | US20050148035 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides |
| 07/07/2005 | US20050148031 Using membrane traversing peptide conjugate comprising reporter element to transfer fluorescent molecules across cell membranes |
| 07/07/2005 | US20050148028 Matrix membrane fusion protein with improved solubility in membrane-free and detergent-free aqueous environments for use in identifying modulators of membrane transport |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050148016 Membrane protein for use as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/07/2005 | US20050148008 Compositions and methods relating to ovarian specific genes and proteins |
| 07/07/2005 | US20050148002 Sequence of surface immobilized polymers utilizing microfluorescence detection |
| 07/07/2005 | US20050147999 Lyme disease vaccines |
| 07/07/2005 | US20050147995 identification, on human chromosome 10, of a tumor suppressor gene. Defects in this gene are associated with the development of cancers, such as gliomas |
| 07/07/2005 | US20050147993 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector |
| 07/07/2005 | US20050147988 Recombinant protein for use as tool in detection of helicobacter infection; immunodiagnostics |
| 07/07/2005 | US20050147985 Mixtures of isobarically labeled analytes and fragments ions derived therefrom |
| 07/07/2005 | US20050147983 Polypeptides of Alicyclobacillus sp. |
| 07/07/2005 | US20050147982 Mixtures of isobarically labeled analytes and fragments ions derived therefrom |
| 07/07/2005 | US20050147971 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/07/2005 | US20050147969 Genes associated with mast cell activation |
| 07/07/2005 | US20050147661 Gelatin derivatives and high-molecular micelle comprising the derivatives |
| 07/07/2005 | US20050147627 Toll-like receptor 5 ligands and methods of use |
| 07/07/2005 | US20050147624 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue |
| 07/07/2005 | US20050147622 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |